Weifa
Weifa is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragerø.
Weifa is one of the world’s largest producers of Metformin hydrochloride and a leading producer of alkaloid opiates. Production facilities follow GMP standards.
History
Weifa was founded by pharmacist Olaf Weider in 1940.Therapeutic areas
Weifa focuses on three therapeutic areas:- Pain management
- Diabetes management
- Food supplements
Products
- bra!: Evening primrose oil.
- Bronkyl: Expectorant effervescent tablet.
- Dexyl: Nasal spray.
- Fanalgin: Pain reliever and fever reducer with an addition of caffeine.
- Ferromax: Iron supplement.
- Fluormax: Fluorine supplements.
- Ibux: A brand name for ibuprofen.
- Ibux Gel: A gel version of Ibux.
- Nazamér: Salt water spray.
- Nazaren: Salt water nasal spray.
- Paracet: A brand name for paracetamol.
- Paracetduo: Similar to Paracet with the addition of caffeine for increased pain relief.
- Proxan: Brand name for naproxen.
- Pyrivir: Relieves symptoms of cold sores.
- Samin: Symptom relief in patients with Osteoarthritis.
- Tigerbalsam: Heat rub.
- Tussin: Cough medicine.
- Weifa-C Nypeekstrakt: Vitamin C from rose hip extract.
- Weifa C-vitamin brusetabletter: Vitamin C effervescent tablets.
- Weifa Kalsium: Calcium supplements.
Active ingredients
- Codeine: Used in pain relievers and cough medicine.
- Metformin: Used in first-line treatment of diabetes mellitus type 2.
- Pholcodine: Used in cough medicine.
Development
With a total of over 99 employees, Weifa is today generating an annual turnover of approximately €40 million. Weifa bases its development on 3 criteria:- International expansion
- Expertise in pharmaceuticals and fine chemicals
- Partnership agreements